Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623749 | SCV000741147 | pathogenic | Inborn genetic diseases | 2015-10-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001049240 | SCV001213282 | likely pathogenic | Developmental and epileptic encephalopathy, 31 | 2019-02-04 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with asparagine at codon 45 of the DNM1 protein (p.Ser45Asn). The serine residue is highly conserved and there is a small physicochemical difference between serine and asparagine. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. TThis variant has been reported to affect DNM1 protein function, also known as Dyn1 (PMID: 11553700, 19084268, 29668686). This variant has been observed to be de novo in an individual affected with DNM1-related encephalopathy (PMID: 28667181). ClinVar contains an entry for this variant (Variation ID: 520840). This variant is not present in population databases (ExAC no frequency). |